000 | 01636nam a2200361 a 4500 | ||
---|---|---|---|
001 | ebr10286191 | ||
003 | CaPaEBR | ||
007 | cr cn||||||||| | ||
008 | 090925s2009 dcua sb 000 0 eng d | ||
020 | _z9780309120883 | ||
020 | _z0309120888 | ||
040 |
_aCaPaEBR _cCaPaEBR |
||
035 | _a(OCoLC)726823396 | ||
043 | _an-us--- | ||
050 | 1 | 4 |
_aRA401.A3 _bB74 2009eb |
245 | 0 | 0 |
_aBreakthrough business models _h[electronic resource] : _bdrug development for rare and neglected diseases and individualized therapies : workshop summary / _cTheresa Wizemann, Sally Robinson, and Robert Giffin ; Forum on Health Sciences Policy, Institute of Medicine of the National Academies. |
260 |
_aWashington, D.C. : _bNational Academies Press, _c2009. |
||
300 |
_a149 p. : _bill. |
||
504 | _aIncludes bibliographical references (p. 104-105). | ||
533 |
_aElectronic reproduction. _bPalo Alto, Calif. : _cebrary, _d2013. _nAvailable via World Wide Web. _nAccess may be limited to ebrary affiliated libraries. |
||
650 | 0 |
_aOrphan drugs _xGovernment policy _zUnited States. |
|
650 | 0 |
_aPharmaceutical policy _zUnited States. |
|
650 | 0 |
_aDrugs _xDesign _zUnited States. |
|
655 | 7 |
_aElectronic books. _2local |
|
700 | 1 | _aWizemann, Theresa M. | |
700 | 1 | _aRobinson, Sally. | |
700 | 1 | _aGiffin, Robert B. | |
710 | 2 |
_aInstitute of Medicine (U.S.). _bForum on Drug Discovery, Development, and Translation. |
|
710 | 2 | _aebrary, Inc. | |
856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/kliuc/Doc?id=10286191 _zAn electronic book accessible through the World Wide Web; click to view |
942 |
_2lcc _cEBK |
||
999 |
_c108559 _d108559 |